| Cause of death . | NMAD− group (n = 1740), n (%) . | NMAD+ (PRCA−) group (n = 45), n (%) . | NMAD+ (PRCA+) group (n = 37), n (%) . | P-valuea . |
|---|---|---|---|---|
| All deaths | 105 (6.0) | 2 (4.4) | 8 (21.6) | <0.001 |
| Progression of thymoma | 35 (2.0) | 1 (2.2) | 3 (8.1) | 0.011 |
| Other malignancies | 21 (1.2) | 0 | 0 | |
| Deterioration of AD | 2 (0.1)b | 0 | 1 (2.7)c | |
| Other disease/unknown | 47 (2.7)d | 1 (2.2)e | 4 (10.8)f | 0.003 |
| Cause of death . | NMAD− group (n = 1740), n (%) . | NMAD+ (PRCA−) group (n = 45), n (%) . | NMAD+ (PRCA+) group (n = 37), n (%) . | P-valuea . |
|---|---|---|---|---|
| All deaths | 105 (6.0) | 2 (4.4) | 8 (21.6) | <0.001 |
| Progression of thymoma | 35 (2.0) | 1 (2.2) | 3 (8.1) | 0.011 |
| Other malignancies | 21 (1.2) | 0 | 0 | |
| Deterioration of AD | 2 (0.1)b | 0 | 1 (2.7)c | |
| Other disease/unknown | 47 (2.7)d | 1 (2.2)e | 4 (10.8)f | 0.003 |
NMAD+ (PRCA+) group was compared with NMAD− and NMAD+ (PRCA−) groups.
Two patients died of late-onset MG developed during postoperative course.
Deterioration of PRCA.
Pneumonia (n = 6), sepsis (n = 1), empyema (n = 1), postoperative infection (n = 1), suicide (n = 1) and unknown disease (n = 37).
Unknown disease.
Pneumonia (n = 1) and unknown disease (n = 3).
AD, autoimmune disease; MG, myasthenia gravis; NMAD, non-myasthenia gravis autoimmune disease; PRCA, pure red cell aplasia.
| Cause of death . | NMAD− group (n = 1740), n (%) . | NMAD+ (PRCA−) group (n = 45), n (%) . | NMAD+ (PRCA+) group (n = 37), n (%) . | P-valuea . |
|---|---|---|---|---|
| All deaths | 105 (6.0) | 2 (4.4) | 8 (21.6) | <0.001 |
| Progression of thymoma | 35 (2.0) | 1 (2.2) | 3 (8.1) | 0.011 |
| Other malignancies | 21 (1.2) | 0 | 0 | |
| Deterioration of AD | 2 (0.1)b | 0 | 1 (2.7)c | |
| Other disease/unknown | 47 (2.7)d | 1 (2.2)e | 4 (10.8)f | 0.003 |
| Cause of death . | NMAD− group (n = 1740), n (%) . | NMAD+ (PRCA−) group (n = 45), n (%) . | NMAD+ (PRCA+) group (n = 37), n (%) . | P-valuea . |
|---|---|---|---|---|
| All deaths | 105 (6.0) | 2 (4.4) | 8 (21.6) | <0.001 |
| Progression of thymoma | 35 (2.0) | 1 (2.2) | 3 (8.1) | 0.011 |
| Other malignancies | 21 (1.2) | 0 | 0 | |
| Deterioration of AD | 2 (0.1)b | 0 | 1 (2.7)c | |
| Other disease/unknown | 47 (2.7)d | 1 (2.2)e | 4 (10.8)f | 0.003 |
NMAD+ (PRCA+) group was compared with NMAD− and NMAD+ (PRCA−) groups.
Two patients died of late-onset MG developed during postoperative course.
Deterioration of PRCA.
Pneumonia (n = 6), sepsis (n = 1), empyema (n = 1), postoperative infection (n = 1), suicide (n = 1) and unknown disease (n = 37).
Unknown disease.
Pneumonia (n = 1) and unknown disease (n = 3).
AD, autoimmune disease; MG, myasthenia gravis; NMAD, non-myasthenia gravis autoimmune disease; PRCA, pure red cell aplasia.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
